The markets opened higher with the Dow gaining 61 points to 13,316 as the nation's trade deficit widened less than expected in July. Nasdaq added 4 points to 3108. On the upside
Sunesis Pharmaceuticals (Nasdaq: SNSS) will increase the sample size of its Phase 3 VALOR trial of its acute myeloid leukemia treatment vosaroxin. Shares of Nokia (NYSE: NOK) rose after the New York Times reported that 32,000 students were forced to work at the Foxconn factory in China to make Apple's (Nasdaq: AAPL) iPhone 5S. Cell Therapeutics (Nasdaq: CTIC) will launch its multiply relapsed or refractory aggressive B-cell non-Hodgkin Lymphoma treatment Pixuvri in Europe this month. On the downside Sequenom (Nasdaq: SQNM) will offer $100 million in convertible senior notes.ThinkEquity analyst Yun Kim downgraded Tibco Software (Nasdaq: TIBX) to a Hold rating. General Growth Properties (NYSE: GGP) rejected 10.5% shareholder Bill Ackman's demand to sell the company. In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 2 on the NYSE and by more than 5 to 3 on Nasdaq. The Russell 2000 which tracks small cap stocks rose 4 points to 843.